AGTR1 and hypertensive disorder: Prior studies had reported that the ARB component of S086-EXP3174 exhibited greater potency towards AT1 receptor and a longer half-life compared to Valsartan in LCZ696, which could potentially lead to clinical benefits for patients with hypertension (18, 26, 27).